Abstract

The main objective of this study is to demonstrate the performance characteristics of the Magic Plate (MP) system when operated upstream of the patient in transmission mode (MPTM). The MPTM is an essential component of a real‐time QA system designed for operation during radiotherapy treatment. Of particular interest is a quantitative study into the influence of the MP on the radiation beam quality at several field sizes and linear accelerator potential differences. The impact is measured through beam perturbation effects such as changes in the skin dose and/or percentage depth dose (PDD) (both in and out of field). The MP was placed in the block tray of a Varian linac head operated at 6, 10 and 18 MV beam energy. To optimize the MPTM operational setup, two conditions were investigated and each setup was compared to the case where no MP is positioned in place (i.e., open field): (i) MPTM alone and (ii) MPTM with a thin passive contamination electron filter. The in‐field and out‐of‐field surface doses of a solid water phantom were investigated for both setups using a Markus plane parallel (Model N23343) and Attix parallel‐plate, MRI model 449 ionization chambers. In addition, the effect on the 2D dose distribution measured by the Delta4 QA system was also investigated. The transmission factor for both of these MPTM setups in the central axis was also investigated using a Farmer ionization chamber (Model 2571A) and an Attix ionization chamber. Measurements were performed for different irradiation field sizes of 5×5 cm2 and 10×10 cm2. The change in the surface dose relative to dmax was measured to be less than 0.5% for the 6 MV, 10 MV, and 18 MV energy beams. Transmission factors measured for both set ups (i & ii above) with 6 MV, 10 MV, and 18 MV at a depth of dmax and a depth of 10 cm were all within 1.6% of open field. The impact of both the bare MPTM and the MPTM with 1 mm buildup on 3D dose distribution in comparison to the open field investigated using the Delta4 system and both the MPTM versions passed standard clinical gamma analysis criteria. Two MPTM operational setups were studied and presented in this article. The results indicate that both versions may be suitable for the new real‐time megavoltage photon treatment delivery QA system under development. However, the bare MPTM appears to be slightly better suited of the two MP versions, as it minimally perturbs the radiation field and does not lead to any significant increase in skin dose to the patient.PACS number(s): 87.50.up, 87.53.Bn, 87.55.N, 87.55.Qr, 87.56.Fc.

Highlights

  • 86 Alrowaili et al.: Beam perturbation characteristics of Magic Plate. External photon beams such as intensity-modulated radiation therapy (IMRT) and, more recently, volumetric-modulated arc therapy (VMAT), which have highly conformal radiation delivery, have increasingly been applied for cancer treatment.[1,2] The main goal of these techniques is to achieve dose distribution of increased conformity to the target volumes, while further reducing the doses to the healthy normal tissue.[3]. VMAT consists of treating the patient by using one or more gantry arcs with continuously varying beam aperture shape, gantry speed, and dose rate.[4,5] The complexity of IMRT and VMAT in treatment delivery places new demands on ensuring the quality of the linear accelerator dose delivery in real time, as its controller must determine in real time the gantry position (VMAT), the multileaf collimator (MLC)

  • The 2D detector arrays based on ionization chambers play a major role in QA, but most of these are not suitable for in vivo 2D dose mapping.[10,13,14,15,16,17,18] 2D semiconductor based on diodes approaches, such as MapCHECK (Sun Nuclear Corp., Melbourne, FL)(5,11,19-21) and the quality control (QA) device,(22) have been used for dose verification

  • The results showed that in general, both versions of the MPTM detector array could potentially be used as a 2D transmission detector

Read more

Summary

Introduction

External photon beams such as intensity-modulated radiation therapy (IMRT) and, more recently, volumetric-modulated arc therapy (VMAT), which have highly conformal radiation delivery, have increasingly been applied for cancer treatment.[1,2] The main goal of these techniques is to achieve dose distribution of increased conformity to the target volumes, while further reducing the doses to the healthy normal tissue.[3]. There is considerable need for real-time in vivo verification of the IMRT and the VMAT that can be achieved by a transmission-type detector placed in the photon beam downstream of the MLC during treatment. The idea of a 2D array transmission detector for real-time in vivo QA in external beam radiation therapy (EBRT) was first proposed by Paliwal et al[28] The transmission chamber was an off-the-shelf device called a Dose Area Product Meter (Gammex RMI, Inc., Middleton, WI)(28) using the concept of dose-area product to monitor the radiation beam in diagnostic applications for the measurement of patient exposure. The concept of a dose-area product was further developed to allow online in vivo comparison of measured dose-area product related to instantaneous MLC leaves opening and compare it with prerecorded data.[29,30]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call